Banco Santander, S.A. Bio N Tech Se Transaction History

Banco Santander, S.A.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$90.91 - $112.75 $82,909 - $102,828	912 Added 18.45%	5,856 $618,000
Q2 2023 Aug 14, 2023	BUY	$102.58 - $129.66 $507,155 - $641,039	4,944 New	4,944 $533,000
Q2 2021 Jul 29, 2021	SELL	$113.32 - $241.49 $1.11 Million - $2.36 Million	-9,755 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$85.73 - $119.5 $836,296 - $1.17 Million	9,755 New	9,755 $1.07 Million

358

38.4M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $24.2B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Banco Santander, S.A., based on Form 13F filings with the SEC.

Stay updated on Banco Santander, S.A. with notifications on news.